CSPC Pharma weighs up diet drug for bigger bottom line - Bamboo Works
| SDMGX Fund | USD 17.72 0.06 0.34% |
Slightly above 62% of Sit Developing's investor base is looking to short. The analysis of overall sentiment of trading Sit Developing Markets mutual fund suggests that many investors are alarmed at this time. Sit Developing's investing sentiment can be driven by a variety of factors including economic data, Sit Developing's earnings reports, geopolitical events, and overall market trends.
Sit |
CSPC Pharma weighs up diet drug for bigger bottom line Bamboo Works
Read at news.google.com
 |
Sit Developing Fundamental Analysis
We analyze Sit Developing's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sit Developing using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sit Developing based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Equity Positions Weight
Equity Positions Weight Comparative Analysis
Sit Developing is rated fifth largest fund in equity positions weight among similar funds. Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
Sit Developing Markets Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sit Developing mutual fund to make a market-neutral strategy. Peer analysis of Sit Developing could also be used in its relative valuation, which is a method of valuing Sit Developing by comparing valuation metrics with similar companies.
Peers
Sit Developing Related Equities
| SESGX | Sit Esg | 0.67 | ||||
| GDGSX | Sit Global | 0.56 | ||||
| GDGIX | Sit Global | 0.56 | ||||
| SSMGX | Sit Small | 0.39 | ||||
| NBNGX | Sit Mid | 0.39 | ||||
| SDVSX | Sit Dividend | 0.34 | ||||
| SDVGX | Sit Dividend | 0.33 | ||||
| SSCDX | Sit Small | 0.32 | ||||
| SDFSX | Sit Small | 0.32 | ||||
| SDMGX | Sit Developing | 0.34 |
Other Information on Investing in Sit Mutual Fund
Sit Developing financial ratios help investors to determine whether Sit Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sit with respect to the benefits of owning Sit Developing security.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |